BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2650216)

  • 1. Selection of cross-match negative HLA-A and/or -B mismatched donors for highly sensitized patients.
    Claas FH; Gijbels Y; von Veen A; de Waal LP; D'Amaro J; Persijn GG; van Rood JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):665-6. PubMed ID: 2650216
    [No Abstract]   [Full Text] [Related]  

  • 2. Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
    Cicciarelli J; Terasaki P
    Transplant Proc; 1989 Feb; 21(1 Pt 1):659-60. PubMed ID: 2650213
    [No Abstract]   [Full Text] [Related]  

  • 3. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
    Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
    [No Abstract]   [Full Text] [Related]  

  • 5. A special strategy to increase the chance of finding cross-match negative kidneys for highly sensitized patients.
    Claas FH; Gijbels Y; van der Velden-de Munck JJ; de Waal LP; D'Amaro J; Hendriks GF; Persijn GG; van Rood JJ
    Transplant Proc; 1988 Oct; 20(5):947-8. PubMed ID: 3055538
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
    Persijn GG; D'Amaro J; de Lange P; Schreuder GM; van Rood JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):656-8. PubMed ID: 2650212
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissection of the respective importance of HLA-A,B,DR matching in 3,789 prospective kidney transplants.
    Hors J; Busson M; Bouteiller AM; Raffoux C; Betuel H; Fauchet R; Tongio MM; Mercier P; Lepetit JC; Dausset J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):687-8. PubMed ID: 3274842
    [No Abstract]   [Full Text] [Related]  

  • 8. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.
    Thompson JS; Bryne JE; Hempel HO; Oldfather JW; Green WF; Crowe DO; Sanfilippo F; MacQueen JM; McCalmon RN; Tardiff GN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):251-4. PubMed ID: 8438290
    [No Abstract]   [Full Text] [Related]  

  • 9. Cadaveric kidneys should be allocated according to the HLA match.
    Opelz G; Wujciak T
    Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 11. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
    Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
    Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposed HLA matching scheme for improved cadaveric kidney allocation.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S
    Transplant Proc; 1995 Feb; 27(1):61-3. PubMed ID: 7879117
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA-B mismatch: an equally strong prognostic factor for kidney transplantation when compared with HLA-DR mismatch.
    Sautner T; Mittlböck M; Herbst F; Schwartz D; Mühlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):224-5. PubMed ID: 8438279
    [No Abstract]   [Full Text] [Related]  

  • 15. Computer program to predict likelihood of finding and HLA-matched donor: methodology, validation, and application.
    Mori M; Graves M; Milford EL; Beatty PG
    Biol Blood Marrow Transplant; 1996 Oct; 2(3):134-44. PubMed ID: 9199756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of flow cytometry cross-matching results on the outcome of cadaveric kidney transplantation.
    Wahlberg J; Bengtsson M; Bergström C; Gannedahl G; Festin R; Lewen G; Frödin L
    Transplant Proc; 1994 Jun; 26(3):1752-3. PubMed ID: 8030118
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular matching for clinical kidney transplantation.
    Takemoto S; Terasaki PI; Maruya E; Park MS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):206. PubMed ID: 7679811
    [No Abstract]   [Full Text] [Related]  

  • 18. Revisiting HLA matching for kidney transplantation.
    Opelz G; Wujciak T; Mytilineos J; Scherer S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):173-5. PubMed ID: 8438263
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
    Bućin D
    Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histocompatibility profile of selected Latin American countries.
    Santiago-Delpín EA
    Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.